BOSTON SCIENTIFIC ACQUIRING BTG
Boston Scientific has reached an agreement on the terms of a recommended offer to acquire BTG plc., a United Kingdom-based company that develops and commercializes products used in minimally-invasive procedures, targeting vascular diseases and cancer, as well as acute care pharmaceuticals. Under the terms of the transaction, holders of BTG’s
MEDTRONIC COMPLETES ACQUISITION OF MAZOR ROBOTICS
Medtronic plc completed the acquisition of Israel-based Mazor Robotics Dec. 19. Under the terms of the acquisition agreement, Mazor shareholders will receive $58.50 per ADS, or $29.25 per ordinary share, in cash. The total value of the transaction is reported at $1.7B, or $1.3B net of Medtronic’s existing stake in Mazor
MERIT MEDICAL ACQUIRES ASSETS OF VASCULAR INSIGHTS DEC 17
Merit Medical Systems Inc., a manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, announced Dec. 17 that it has acquired substantially all of the assets of Vascular Insights LLC, based in Quincy, Massachusetts. Vascular Insights’ primary assets are the ClariVein IC and ClariVein
ADVANCED DERMATOLOGY & COSMETIC SURGERY NAMES CIO, PURCHASING MANAGER
Advanced Dermatology and Cosmetic Surgery, the largest dermatology practice in the country based in Maitland, Florida, named Steve Essayan as chief information officer Dec. 12. Essayan joins Advanced Dermatology with more than 30 years of experience in all aspects of information technology, including operations, infrastructure, and applications development. Most recently
VEIN CLINICS OF AMERICA NAMES ALTON SHADER TO PRESIDENT AND CEO POST
Alton Shader, formerly president of Hill-Rom’s global Front Line Care business, has been named president and CEO of Vein Clinics of America (VCA), a Frazier Healthcare Partners portfolio company, replacing Hans Thunem. A VCA release indicated that Thunem, who was CEO for four years, made the decision earlier in 2018
BOOK REVIEWS: ‘A GUIDE TO TREATING FACE VEINS’
‘A Wonderful Resource’ By Joseph D. Raffetto, MD “A Guide to Treating Face Veins” is a wonderful resource and compilation of work by Dr. Ronald Bush and Mrs. Peggy Bush. Facial veins are uncommonly treated in most clinical practices but is a common problem among patients who seek medical
VEIN911 CEO FORMS MANAGEMENT SERVICE FOR INDEPENDENT PRACTICES
The CEO of Vein911 Vein Treatment Centers, 21-year cancer survivor and healthcare industry veteran Chris Pittman, MD, has launched Health Performance Specialists (HPS), a national Management Services Organization for independent physicians. HPS helps independent physicians compete, succeed and thrive in today’s medical practice environment. The organization is designed to disrupt current healthcare
ACP CHANGES ITS NAME TO AMERICAN VEIN & LYMPHATIC SOCIETY; AVLS OFFICIAL STATEMENT
By Vanessa Salvia The American College of Phlebology (ACP) has changed its name to the American Vein & Lymphatic Society (AVLS). The organization is still working on its new logo. The American College of Phlebology Foundation will be known as the Foundation for Venous and Lymphatic Disease, or FVLD. During
BOSTON SCIENTIFIC ACQUIRING BTG
Boston Scientific has reached an agreement on the terms of a recommended offer to acquire BTG plc., a United Kingdom-based company that develops and commercializes products used in minimally-invasive procedures, targeting vascular diseases and cancer, as well as acute care pharmaceuticals. Under the terms of the transaction, holders
26,000-PERSON STUDY: FISH OIL AND VITAMIN D PILLS NO GUARD AGAINST CANCER OR SERIOUS HEART TROUBLE
By Liz Szabo Kaiser Health News A widely anticipated study has concluded that neither vitamin D nor fish oil supplements prevent cancer or serious heart-related problems in healthy older people, according to research presented Nov. 10 at the American Heart Association Scientific Sessions. Researchers defined serious heart problems as the